Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.
Catalent Pharma Solutions plans to invest more than $27 million to commercialize Zydis Ultra, which allows an increased drug load and taste masking to be incorporated into the company’s Zydis oral disintegrating tablet (ODT), a freeze-dried tablet that disperses in the mouth without water. The investment includes new Zydis lines, changes to the Swindon, UK facility, and a custom suite for commercial equipment. The facility currently produces one billion ODT doses annually.
In a March 7, 2019 press statement announcing the investment, the company explained that Zydis Ultra enables a patented drug coating to be added to a product’s formulation, allowing the dosage of active ingredient to be up to four times higher than a conventional Zydis ODT, while maintaining its speed of dispersion and mouth feel. The coating will expand the types of drug candidates that can be formulated to include analgesics, anti-allergy treatments, and anti-infectives, Catalent reports.
Catalent told Pharmaceutical Technology that Zydis Ultra is being used for prescription and over-the-counter development molecules, with one product moving toward commercialization. More than 36 products have been launched using Zydis technology, the company reports.
Source: Catalent
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.